EVO-46130

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameEVO-46130

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionImmunomodulators

TargetsUpdating

Therapy Area/IndicationsMetapneumovirus infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEvec Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesEvec Inc

Active IndicationsN/A

Inactive IndicationsMetapneumovirus infections

ATC CodeN/A